Horizons in Cancer Research -

Horizons in Cancer Research

Volume 78

Hiroto S. Watanabe (Herausgeber)

Buch | Hardcover
248 Seiten
2020
Nova Science Publishers Inc (Verlag)
978-1-5361-8773-1 (ISBN)
276,80 inkl. MwSt
This compilation begins by discussing the common pediatric brain tumors, their key oncogenic drivers and signaling pathways. An update on the clinical trials against druggable targets is also provided. An outline of the metabolizing pathways in cancer and the mode of action of aerobic glycolysis in cancer cells is presented, also highlighting the roles of nanotechnology in energy-based cancer therapies. The authors review recent studies that characterize the specific mechanisms involved in mediating -tocotrienol reversal of epithelial-to mesenchymal transition in malignant breast cancer cells. The cytotoxic effects of Mannich bases derived from kojic acid on A375 human malignant melanoma are discussed and MRC-5 human lung cell lines are investigated using a sulphorhodamine B assay. Additionally, the cytotoxic effects and mechanisms displayed by metformin are assessed, alone or in combination with other agents. A better understanding of metformin-induced metabolic changes could aid in the discovery of new drugs, enhancing the efficacy of current melanoma therapeutics. In closing, the authors explore the way in which physical activity and exercise are negatively correlated to most type of cancers, as exercise shares common underlying metabolic pathways with those of some bioactive food compounds, such as polyphenols.

Preface; Targeted Therapy in Pediatric Brain Tumors; Targeting Energy as a New Strategy to Destroy Cancer Cells; Intracellular Mechanisms Involved in Mediating y-Tocotrienol Reversal of Epithelial-to Mesenchymal Transition (EMT) in Breast Cancer Cells; Antimelanogenic Effects of Kojic Acid Deriva-tives; The Therapeutic Potential of Metformin for Melanoma; Physical Activity, Exercise as Protective Therapies for Chemotherapy-Induced Cardiotoxicity; Index.

Erscheinungsdatum
Verlagsort New York
Sprache englisch
Maße 155 x 230 mm
Gewicht 502 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-5361-8773-9 / 1536187739
ISBN-13 978-1-5361-8773-1 / 9781536187731
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
36,00